Immunogenicity and Reactogenicity of Ad26.COV2.S in Korean Adults: A Prospective Cohort Study
한국 성인에서 Ad26.COV2.S의 면역원성과 반응성: 전향적 코호트 연구
Article
Published on
Journal: Journal of Korean medical science [Category] COVID19(2023년), MERS, SARS, 변종, 진단,
Journal: Journal of Korean medical science [Category] COVID19(2023년), MERS, SARS, 변종, 진단,
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Ad26
Ad26.COV2.S
Adenovirus
Adenovirus Vector
Adverse
adverse event
adverse events
AEs
anti-S IgG
Anti-spike
baseline
cellular immunity
conducted
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
decrease
Delta
Dilution
enrolled
enzyme
enzyme-linked immunospot assay
evaluated
fatigue
Fever
followed by
geometric mean
geometric mean titers
GMT
GMTs
GRADE
Humoral immunity
IgG antibody
immunogenic
immunogenicity
injection site pain
interferon
interferon-γ
Korean
mononuclear cell
MOST
myalgia
NAb titer
Neutralizing
Neutralizing activity
neutralizing antibody responses
omicron
Omicron variant
Omicron variants
outcome
pandemic
participant
Peripheral blood
Prospective
prospective cohort study
resolved
respiratory
Safe
SARS-CoV-2
serious AEs
severe acute respiratory syndrome Coronavirus
Single-dose
South Korea
T-cell immunity
T-cell Response
T-cell responses
the median
U/mL
university hospital
vaccination
Vaccines
variant
variants
Viral
Viral variants
waning immunity
wild-type
WT SARS-CoV-2
[DOI] 10.3346/jkms.2022.37.e210 PMC 바로가기 [Article Type] Article
[DOI] 10.3346/jkms.2022.37.e210 PMC 바로가기 [Article Type] Article